Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer.

British journal of cancer

Volumn 110, Issue 8, 2014, Pages 2116-2122

  Zheng, J ^a   Nagda, D A ^a   Lajud, S A ^a   Kumar, S ^a   Mouchli, A ^a   Bezpalko, O ^a   O'Malley Jr , B W ^a   Li, D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BILIVERDIN; HEME; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; HUMAN; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; BILIVERDINE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HEME; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84901854935     PISSN: None     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.98     Document Type: Article

References (0)